Supernus Pharmaceuticals reported $107.22M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8881M 534M
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Aerie Pharmaceuticals AERI:US $ 58.69M 1.5M
Ani Pharmaceuticals ANIP:US $ 64.18M 12.7M
Aphria Inc APH:CN C$ 221.95M 18.21M
Aurora Cannabis Inc ACB:CN 206.69M 140.28M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Canopy Growth Corp WEED:CN C$ 326.26M 54.75M
Cara Therapeutics CARA:US $ 30.88M 5.38M
Corcept Therapeutics CORT:US $ 59.64M 154K
Eisai 4523:JP Y 143487M 10048M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Horizon Pharma HZNP:US $ 694.03M 191.61M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Lannett LCI:US $ 139.83M 30.31M
Marinus Pharmaceuticals MRNS:US $ 25.39M 3.58M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Perrigo Ordinary Shares PRGO:US $ 1107M 148.4M
Pfizer PFE:US $ 13063M 3998M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Supernus Pharmaceuticals SUPN:US $ 107.22M 10.5M
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
United Therapeutics UTHR:US $ 226.6M 217.3M
Xeris Pharmaceuticals Inc XERS:US $ 34.69M 9.76M